Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247103.RAX1I2Ae9MJzE7qGdU9q1mH6CtJHxiamqJ7-YQ3VV2iEo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247103.RAX1I2Ae9MJzE7qGdU9q1mH6CtJHxiamqJ7-YQ3VV2iEo130_assertion type Assertion NP1247103.RAX1I2Ae9MJzE7qGdU9q1mH6CtJHxiamqJ7-YQ3VV2iEo130_head.
- NP1247103.RAX1I2Ae9MJzE7qGdU9q1mH6CtJHxiamqJ7-YQ3VV2iEo130_assertion description "[Early results of clinical studies with anti-CTLA4 and anti-PDL1 are propelling immune modulating drugs to the forefront of emerging treatments for BCa.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247103.RAX1I2Ae9MJzE7qGdU9q1mH6CtJHxiamqJ7-YQ3VV2iEo130_provenance.
- NP1247103.RAX1I2Ae9MJzE7qGdU9q1mH6CtJHxiamqJ7-YQ3VV2iEo130_assertion evidence source_evidence_literature NP1247103.RAX1I2Ae9MJzE7qGdU9q1mH6CtJHxiamqJ7-YQ3VV2iEo130_provenance.
- NP1247103.RAX1I2Ae9MJzE7qGdU9q1mH6CtJHxiamqJ7-YQ3VV2iEo130_assertion SIO_000772 25498841 NP1247103.RAX1I2Ae9MJzE7qGdU9q1mH6CtJHxiamqJ7-YQ3VV2iEo130_provenance.
- NP1247103.RAX1I2Ae9MJzE7qGdU9q1mH6CtJHxiamqJ7-YQ3VV2iEo130_assertion wasDerivedFrom befree-2016 NP1247103.RAX1I2Ae9MJzE7qGdU9q1mH6CtJHxiamqJ7-YQ3VV2iEo130_provenance.
- NP1247103.RAX1I2Ae9MJzE7qGdU9q1mH6CtJHxiamqJ7-YQ3VV2iEo130_assertion wasGeneratedBy ECO_0000203 NP1247103.RAX1I2Ae9MJzE7qGdU9q1mH6CtJHxiamqJ7-YQ3VV2iEo130_provenance.